TNF and ovarian carcinoma: High levels of expression of TNF-α have been observed in ovarian carcinoma [38], [39], [40], particularly of the high grade serous type [41], and an anti-TNF-α antibody, infliximab (RemicadeTM), has been investigated for its efficacy against ovarian cancer [42].